Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.46M Sell
805
-73
-8% -$127K 0.37% 51
2026
Q2
$1.75M Sell
878
-378
-30% -$602K 0.44% 46
2026
Q1
$1.66M Buy
1,256
+353
+39% +$484K 0.34% 62
2025
Q4
$967K Buy
903
+104
+13% +$108K 0.2% 93
2025
Q3
$773K Sell
799
-42
-5% -$33K 0.22% 92
2025
Q2
$674K Buy
841
+55
+7% +$39.5K 0.15% 142
2025
Q1
$521K Sell
786
-11
-1% -$8K 0.16% 150
2024
Q4
$553K Sell
797
-258
-24% -$185K 0.17% 157
2024
Q3
$879K Buy
+1,055
New +$943K 0.26% 65

Other funds holding ASML

Net Worth Advisory Group's ASML Position: Q3 2026 in Review

Net Worth Advisory Group reduced its ASML (ASML) stake by 8.3% in Q3 2026, selling an estimated $127K and leaving 805 shares worth $1.46M. The position accounts for 0.37% of the portfolio, ranked #51.

Net Worth Advisory Group first reported a position in ASML in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.75M in Q2 2026. 475 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

  • Net Worth Advisory Group held 805 shares of ASML worth $1.46M as of Q3 2026.
  • Net Worth Advisory Group sold 73 ASML shares in Q3 2026, an estimated $127K.
  • ASML made up 0.37% of Net Worth Advisory Group's portfolio in Q3 2026, its #51 holding.
  • Net Worth Advisory Group first reported a position in ASML in Q3 2024 and has held it in 9 quarters since.
  • Net Worth Advisory Group's ASML position peaked at $1.75M in Q2 2026.
  • 475 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on Net Worth Advisory Group's 13F filing for Q3 2026, filed 20 Oct 2026.